Annovis Bio Inc
(ANVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 45,686 | 47,455 | 49,224 | 5,603 | 8,075 |
| TOTAL | $46,002 | $47,651 | $49,496 | $5,965 | $8,119 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $46,002 | $47,651 | $49,496 | $5,965 | $8,119 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 688 | 290 | 115 | 825 | 342 |
| Accrued Expenses | 818 | 831 | 769 | 772 | 237 |
| TOTAL | $1,507 | $1,121 | $884 | $1,597 | $578 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,507 | $1,121 | $884 | $1,597 | $578 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,164 | 8,101 | 8,101 | 6,947 | 6,947 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -28,726 | -22,812 | -19,963 | -17,439 | -14,239 |
| TOTAL | $44,495 | $46,530 | $48,612 | $4,368 | $7,541 |
| Total Liabilities And Equity | $46,002 | $47,651 | $49,496 | $5,965 | $8,119 |